Dustin Chapin

机构：WinnMed, Mayo Clinic in Florida

发表论文 10 篇 · 总被引 30 次 · h-index 4

代表论文

Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma (2024 · Blood Cancer Journal · 被引 6)
Ibrutinib, lenalidomide and dexamethasone in patients with relapsed and/or refractory multiple myeloma: Phase I trial results (2022 · Hematological Oncology · 被引 6)
A phase II study of ibrutinib in combination with ixazomib in patients with Waldenström macroglobulinaemia (2024 · British Journal of Haematology · 被引 4)
Phase II Study of Ibrutinib in Combination with Ixazomib in Patients with Waldenström Macroglobulinemia (WM) (2022 · Blood · 被引 4)
Phase II Trial of Elotuzumab with Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM) in the Post-Daratumumab Progression Setting (2022 · Blood · 被引 4)
Peri-Transplant and Maintenance Daratumumab for Minimal Residual Disease (MRD) Eradication in Transplant-Eligible Multiple Myeloma (MM) Patients (2022 · Blood · 被引 2)